Elevated Preoperative Neutrophil to Lymphocyte Ratio Predicts Poor Survival Following Resection in Late Stage Gastric Cancer

被引:224
作者
Jung, Mi Ran [1 ]
Park, Young Kyu [1 ]
Jeong, Oh [1 ]
Seon, Jang Won [1 ]
Ryu, Seong Yeob [1 ]
Kim, Dong Yi [1 ]
Kim, Young Jin [1 ]
机构
[1] Chonnam Natl Univ, Div Gastroenterol Surg, Dept Surg, Sch Med, Kwangju, South Korea
关键词
gastric cancer; neutrophil to lymphocyte ratio; inflammation; prognostic factor; disease-free survival; COLORECTAL-CANCER; HEPATOCELLULAR-CARCINOMA; SYSTEMIC INFLAMMATION; IMMUNE-RESPONSE; RECTAL-CANCER; PROGNOSIS; CELLS; CHOLANGIOCARCINOMA; ANGIOGENESIS; ELASTASE;
D O I
10.1002/jso.21986
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Elevated neutrophil to lymphocyte ratio (N/L ratio) has been shown to be a prognostic indicator in various cancers. We aimed to investigate the prognostic significance of the preoperative N/L ratio in late stage gastric cancer. Methods: From April 2004 to August 2007, 293 patients who had undergone gastrectomy with curative intent for the AJCC/UICC TNM Stage III or IV gastric cancer were included. N/L ratio was calculated from lymphocyte and neutrophil counts on routine blood tests taken prior to surgery. Results: The median follow-up time for surviving patients was 38.2 months (4.2-65.5 months) and median preoperative N/L ratio was 2.06 (range 0.47-19.73). Subjects were dichotomized at the N/L value of 2.0. A multivariate analysis established a significant relationship between the N/L ratio and overall survival (HR = 1.609; 95% confidence interval, CI, 1.144-2.264; P = 0.006). The cutoff value up to 3.0, the value of 75 percentiles, showed a significant prognostic effect on disease-free survival (HR = 1.654; 95% CI, 1.088-2.515; P = 0.019). Conclusions: The results suggest that the elevated preoperative N/L ratio predicts poor disease-free and overall survival following resection for late stage gastric cancer. It may be utilized as a simple, reliable prognostic factor for risk stratification and will provide better treatment allocation. J. Surg. Oncol. 2011; 104:504-510. (C) 2011 Wiley-Liss, Inc.
引用
收藏
页码:504 / 510
页数:7
相关论文
共 35 条
[1]   The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment [J].
Aliustaoglu, Mehmet ;
Bilici, Ahmet ;
Ustaalioglu, Bala Basak Oven ;
Konya, Volkan ;
Gucun, Murat ;
Seker, Mesut ;
Gumus, Mahmut .
MEDICAL ONCOLOGY, 2010, 27 (04) :1060-1065
[2]   Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer [J].
An, Xin ;
Ding, Pei-Rong ;
Li, Yu-Hong ;
Wang, Feng-Hua ;
Shi, Yan-Xia ;
Wang, Zhi-Qiang ;
He, You-Jian ;
Xu, Rui-Hua ;
Jiang, Wen-Qi .
BIOMARKERS, 2010, 15 (06) :516-522
[3]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[4]   ABSOLUTE GRANULOCYTE, LYMPHOCYTE, AND MONOCYTE COUNTS - USEFUL DETERMINANTS OF PROGNOSIS FOR PATIENTS WITH METASTATIC CANCER OF THE STOMACH [J].
BRUCKNER, HW ;
LAVIN, PT ;
STORCH, JA ;
LIVSTONE, EM ;
PLAXE, SC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 247 (07) :1004-1006
[5]  
Clark E J, 2007, HPB (Oxford), V9, P456, DOI 10.1080/13651820701774891
[6]   Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867
[7]  
Di Carlo E, 2003, CHEM IMMUNOL, V83, P182
[8]   Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma [J].
Donskov, F ;
Bennedsgaard, KM ;
Hokland, M ;
Marcussen, N ;
Fisker, R ;
Madsen, HHT ;
Fode, K ;
von der Maase, H .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (08) :729-739
[9]  
ELHAG A, 1987, J IMMUNOL, V139, P2406
[10]   Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma [J].
Gomez, D. ;
Farid, S. ;
Malik, H. Z. ;
Young, A. L. ;
Toogood, G. J. ;
Lodge, J. P. A. ;
Prasad, K. R. .
WORLD JOURNAL OF SURGERY, 2008, 32 (08) :1757-1762